Biotech RadarJobs updated

COMPANY

Hopstem Biotechnology

hopstem.com ↗

Clinical Phase 1

Profile checked Oct 10, 2026

Keywords: Chronic Ischemic Stroke hNPC01

1Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT06299033A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic StrokePhase 1Unknown status (ClinicalTrials.gov)Nov 9, 2023Aug 30, 2024 (estimated)
Feedback